Why the study?
Do surrogate insulin resistance indices (TyG, VAI, LAP, METS-IR, and TG/HDL-C ratio) associate with and accurately identify diabetic retinopathy in patients with type 2 diabetes?
Do surrogate insulin resistance indices (TyG, VAI, LAP, METS-IR, and TG/HDL-C ratio) associate with and accurately identify diabetic retinopathy in patients with type 2 diabetes?
Answers are grounded in this paper and cite their sources.
Surrogate insulin resistance indices, particularly VAI and LAP, exhibit significant nonlinear associations with diabetic retinopathy and offer good diagnostic discrimination (AUC 0.758–0.780) using routine clinical measurements in patients with type 2 diabetes.
This study assessed the association between DR and surrogate insulin resistance (IR) indices, including TyG, VAI, LAP, METS-IR, and the TG/HDL-C ratio, and evaluated their ability to identify DR in patients with type 2 diabetes (T2D). In this cross-sectional, matched case-control study, patients with T2D were classified according to DR status. Associations between surrogate IR indices and DR and their diagnostic performance were examined using RCS models, Generalized linear mixed-effects models, Threshold effect analysis, and ROC analysis. A total of 1230 patients with T2D were included (615 with DR; 615 without). RCS models showed significant nonlinear associations between all indices and DR, with higher values associated with increased odds of DR. VAI showed the strongest association, with ORs (95% CI) of 1.69 (1.24–2.30) and 2.40 (1.72–3.35) for the second and third tertiles, respectively. LAP, METS-IR, and the TG/HDL-C ratio were also significantly associated with DR, whereas TyG was not significantly associated. All indices demonstrated good discriminative ability (AUC ≥ 0.758), with LAP showing the highest AUC (0.780, 95% CI: 0.722–0.837). Surrogate IR indices showed significant nonlinear associations with DR, supporting a link between IR and DR pathophysiology. These indices may serve as practical tools for identifying DR using routine clinical data.
No takes yet. Share an insight, caveat, or question.
Naeini et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: